CAS 99873-43-5

Droxinostat

Description:

Droxinostat is a chemical compound classified as a histone deacetylase (HDAC) inhibitor, which plays a significant role in the regulation of gene expression. It is primarily investigated for its potential therapeutic applications in cancer treatment and other diseases characterized by abnormal cell growth. The compound exhibits a unique mechanism of action by altering the acetylation status of histones, leading to changes in chromatin structure and gene transcription. Droxinostat is known for its ability to induce cell cycle arrest and apoptosis in cancer cells, making it a subject of interest in oncology research. Additionally, it may have implications in the treatment of neurodegenerative disorders due to its effects on neuronal survival and function. The substance is typically administered in a controlled setting, and its pharmacokinetics, safety profile, and efficacy are subjects of ongoing clinical studies. As with many HDAC inhibitors, potential side effects may include gastrointestinal disturbances and hematological changes, necessitating careful monitoring during treatment.

Droxinostat

CAS: 99873-43-5

Formula: C₁₁H₁₄ClNO₃

Purity: 96%

Color and Shape: Solid

Molecular weight: 243.6868

Ref: IN-DA01B150

Droxinostat

CAS: 99873-43-5

Droxinostat

Purity: ≥98%

Molecular weight: 243.69g/mol

Ref: 54-BUP11106

Droxinostat

CAS: 99873-43-5

Formula: C₁₁H₁₄ClNO₃

Molecular weight: 243.69

Ref: 7W-GP4388

Droxinostat

CAS: 99873-43-5

Droxinostat (NS 41080) is a selective inhibitor of HDAC, mostly for HDACs 6 and 8 with IC50 of 2.47 μM and 1.46 μM, greater than 8-fold selective against HDAC3

Formula: C₁₁H₁₄ClNO₃

Purity: 99.83%

Color and Shape: Solid

Molecular weight: 243.69

Ref: TM-T6481

DROXINOSTAT

CAS: 99873-43-5

Purity: 96%

Molecular weight: 243.6900024

Ref: 10-F826264

Droxinostat

Controlled Product

CAS: 99873-43-5

Formula: C₁₁H₁₄ClNO₃

Color and Shape: Neat

Molecular weight: 243.687

Ref: TR-D689890